phenylglyoxal has been researched along with Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Granchi, C | 1 |
| Austin, CA; Burgos-Morón, E; Calderón-Montaño, JM; López-Lázaro, M; Mateos, S; Orta, ML; Pastor, N; Perez-Guerrero, C | 1 |
1 review(s) available for phenylglyoxal and Neoplasms
| Article | Year |
|---|---|
ATP citrate lyase (ACLY) inhibitors: An anti-cancer strategy at the crossroads of glucose and lipid metabolism.
Topics: Antineoplastic Agents; ATP Citrate (pro-S)-Lyase; Dose-Response Relationship, Drug; Glucose; Humans; Lipid Metabolism; Molecular Structure; Neoplasms; Structure-Activity Relationship | 2018 |
1 other study(ies) available for phenylglyoxal and Neoplasms
| Article | Year |
|---|---|
Guanidine-reactive agent phenylglyoxal induces DNA damage and cancer cell death.
Topics: Animals; Antineoplastic Agents; Antioxidants; Apoptosis; Catalase; Cell Death; Cell Proliferation; CHO Cells; Comet Assay; Cricetinae; Cricetulus; DNA Damage; DNA End-Joining Repair; DNA Repair; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Flow Cytometry; Fluorescent Antibody Technique; Histones; Humans; Hydrogen Peroxide; K562 Cells; Neoplasms; Nucleic Acid Conformation; Oxidative Stress; Phenylglyoxal; Recombinational DNA Repair; Time Factors | 2012 |